RecruitingPhase not listedNCT02071134
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Sponsor: Boston Scientific Corporation
Houston, TX · San Antonio, TX · Sherman, TX · +26 more sites
Parkinson's Disease clinical trials in San Antonio, TX
14 recruiting parkinson's disease studies with a site in San Antonio, TX.
All trials in San Antonio, TX · All Parkinson's Disease trials
RecruitingPhase 3NCT06312176
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · +43 more sites
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Dallas, TX · El Paso, TX · Houston, TX · +36 more sites
RecruitingPhase 3NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Sponsor: Merck Sharp & Dohme LLC
Fort Worth, TX · Houston, TX · San Antonio, TX · +50 more sites
RecruitingPhase 3NCT06966700
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Sponsor: Merck Sharp & Dohme LLC
Abilene, TX · Dallas, TX · +61 more sites
RecruitingPhase 3NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Sponsor: AstraZeneca
Austin, TX · Fort Worth, TX · Houston, TX · +60 more sites
RecruitingPhase 2NCT06996652
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Sponsor: Yale University
Houston, TX · San Antonio, TX · +16 more sites
RecruitingPhase 1NCT07161414
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
Sponsor: AstraZeneca
San Antonio, TX · +2 more sites
RecruitingPhase not listedNCT04994015
Parkinson's Foundation PD GENEration Genetic Registry
Sponsor: Parkinson's Foundation
Houston, TX · San Antonio, TX · +60 more sites
RecruitingPhase 4NCT04373317
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Sponsor: VA Office of Research and Development
Houston, TX · San Antonio, TX · +22 more sites
RecruitingNot applicableNCT07636720
Sensing in Sleep Deep Brain Stimulation
Sponsor: The University of Texas Health Science Center at San Antonio
San Antonio, TX
RecruitingNot applicableNCT06508801
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
Sponsor: The University of Texas Health Science Center at San Antonio
San Antonio, TX
RecruitingPhase 4NCT05590637
Comparing Antipsychotic Medications in LBD Over Time
Sponsor: The University of Texas Health Science Center at San Antonio
San Antonio, TX
Not yet recruitingNot applicableNCT07356414
SwallowFIT Study in Parkinson's Disease
Sponsor: The University of Texas Health Science Center at San Antonio
San Antonio, TX
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.